ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lessened its position in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 23.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 419,899 shares of the company's stock after selling 126,603 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.52% of ZimVie worth $5,858,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC lifted its stake in shares of ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after purchasing an additional 1,508 shares during the last quarter. EMC Capital Management boosted its stake in ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after buying an additional 4,414 shares during the period. Principal Financial Group Inc. raised its stake in shares of ZimVie by 9.8% in the 4th quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock valued at $266,000 after acquiring an additional 1,702 shares during the period. Bailard Inc. raised its stake in shares of ZimVie by 35.0% in the 4th quarter. Bailard Inc. now owns 21,194 shares of the company's stock valued at $296,000 after acquiring an additional 5,494 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of ZimVie in the 3rd quarter worth approximately $470,000. 95.63% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Separately, Needham & Company LLC restated a "hold" rating on shares of ZimVie in a research note on Thursday, March 13th.

ZimVie Trading Down 5.2 %

NASDAQ ZIMV traded down $0.60 during trading on Friday, hitting $10.91. The stock had a trading volume of 142,158 shares, compared to its average volume of 233,905. The company has a market capitalization of $301.96 million, a PE ratio of -0.83 and a beta of 2.10. ZimVie Inc. has a twelve month low of $10.75 and a twelve month high of $22.40. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The firm has a 50 day moving average price of $13.13 and a 200 day moving average price of $14.09.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. As a group, equities research analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.